Mark Bodmer
2019
In 2019, Mark Bodmer earned a total compensation of $1.5M as Chief Scientific Officer at Evelo Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $134,400 |
|---|---|
| Option Awards | $930,000 |
| Salary | $420,000 |
| Other | $3,100 |
| Total | $1,487,500 |
Bodmer received $930K in option awards, accounting for 63% of the total pay in 2019.
Bodmer also received $134.4K in non-equity incentive plan, $420K in salary and $3.1K in other compensation.
Rankings
In 2019, Mark Bodmer's compensation ranked 7,351st out of 13,971 executives tracked by ExecPay. In other words, Bodmer earned more than 47.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,351 out of 13,971 | 47th |
Division Manufacturing | 2,838 out of 5,701 | 50th |
Major group Chemicals And Allied Products | 1,062 out of 2,200 | 52nd |
Industry group Drugs | 904 out of 1,886 | 52nd |
Industry Pharmaceutical Preparations | 670 out of 1,398 | 52nd |
Source: SEC filing on April 27, 2020.
Bodmer's colleagues
We found two more compensation records of executives who worked with Mark Bodmer at Evelo Biosciences in 2019.